New conflict of interest rules led it to cancel a July 2008 panel for Sabril because one key expert no longer qualified.

FORBES: Magazine Article

And No Child Left Behind has forced attention on that because of the rules that the reporters on the first panel were talking about, and just because it's forced a national conversation about this.

NPR: Reauthorizing No Child Left Behind: Schools React

Two days before, a panel at the American College of Cardiology had said that because an artery-imaging study showed no added benefit from Zetia to Zocor, doctors should dramatically scale back their use of Zetia and Vytorin.

FORBES: Schering-Plough Backdates Trial